Syntermed Announces New Software Applications for Emory Toolbox 4.0

Share Article

At the recent ASNC annual meeting, Syntermed, Inc. unveiled the Emory Toolbox 4.0's newest diagnostic capabilities: FlowTool™ for cardiac PET studies, SyncTool™ with AdreView Tools for the quantitative evaluation of heart failure, and post factor reorientation for either SPECT or PET tomogram misalignment.

Emory Toolbox 4.0 with Syntermed IDS™ delivers the (nuclear cardiology) industry’s first diagnostic decision support. It is designed to help clinicians maintain high quality interpretations and deliver high value reports in less time.-- Michael Lee

At the recent ASNC annual meeting, Syntermed, Inc. unveiled the Emory Toolbox 4.0's newest diagnostic capabilities: FlowTool™ for cardiac PET studies, SyncTool™ with AdreView Tools for the quantitative evaluation of heart failure, and post factor reorientation for either SPECT or PET tomogram misalignment.

"’As risk based payment models mature, every medical procedure, including diagnostic imaging, is under greater scrutiny and providers must be able to effectively demonstrate the value of procedures," says Michael Lee, CEO, Syntermed, Inc. "Emory Toolbox 4.0 with Syntermed IDS™ delivers the industry’s first diagnostic decision support. It is designed to help clinicians maintain high-quality interpretations and deliver high-value reports in less time."

Within Emory Toolbox 4.0, new benefits include: Flowtool, a new coronary blood flow analysis tool that computes absolute blood flow and coronary flow reserve from dynamic PET studies. This application applies to triple vessel and endothelial diseases. In addition, Emory Toolbox 4.0 now has post facto reorientation. This feature assists the physician with image interpretation correction for SPECT or PET tomogram misalignment in real time thus eliminating the need to reprocess.

Emory Toolbox 4.0 also includes SyncTool for LV dyssynchrony. Synctool in conjunction with the available AdreView Tools delivers the only quantitative software on the market for evaluating two avenues of congestive heart failure. All of these products take the data-driven technology of SPECT and PET myocardial perfusion imaging to higher levels both clinically and as practice builders.

"Because version 4.0 is built on a .NET architecture, we will be able to bring our strong pipeline of new features to the market faster than ever before,” adds Lee. Syntermed recently announced new partnerships in Europe, Asia, and South America. For more information, visit Syntermed's new website [http://www.syntermed.com/#!products/c1utx

About Syntermed, Inc.
This Atlanta-based imaging and informatics software company is advancing the field of nuclear medicine quantification with news levels of clinical decision support under the brand Syntermed IDS™. Since 1999, Syntermed software has been utilized on SPECT and PET imaging systems. Emory Toolbox now has many advanced cardiac tools applicable to the diagnosis of heart failure. Syntermed also has quantitative software for PET-FDG and SPECT brain imaging studies under the NeuroQ™ brand. All of Syntermed's software is broadly compatible with existing nuclear medicine workstations PC/ MAC that support a Microsoft® Windows® operating system. The cloud-based Syntermed Live system enables the physicians around-the- clock secure, digital access to reports and dynamic images from your laptop or workstation.

Note: Emory Toolbox is a trademark of Emory University
AdreView Tools is a trademark of General Electric and its subsidiaries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Karen Roberts
Visit website